Rentschler Biotechnologie GmbH & Co. Commissions New 500 Liter GMP Manufacturing Suites
7/23/2007 12:19:43 PM
Laupheim, July 23, 2007 -- With the commissioning of two new GMP manufacturing suites, Rentschler Biotechnologie looks forward to completing the first phase expansion of its operations. Both systems will be used to produce therapeutic proteins and monoclonal antibodies.